IQ Consortium Annual Reports
Since being established in 2010, the IQ Consortium has grown into a highly active and dynamic organization engaged in addressing a broad spectrum of scientific and regulatory challenges in pharmaceutical development. With more than three dozen member companies and nearly two thousand participants, the Consortium offers a forum for pharmaceutical scientists to share important knowledge about emerging issues and best practices, identify and address common challenges, and initiate new initiatives on promising areas of science and technology.
IQ's annual reports provide insight into the priorities and achievements of the Consortium and its members, highlighting growth in the Consortium as a whole as well as specific initiatives that have led to changes in approaches taken by industry leaders and regulatory authorities. We invite you to read these reports to learn more, and to contact us if you would like to become involved with our organization.